The Role of the Mitochondrial NCX in the Mechanism of Neurodegeneration in Parkinson's Disease

被引:25
|
作者
Wood-Kaczmar, Alison [1 ]
Deas, Emma [1 ]
Wood, Nicholas W. [1 ]
Abramov, Andrey Y. [1 ]
机构
[1] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
PINK1; Mitochondria; NCX; Calcium; Parkinson's disease; NA+/CA2+ EXCHANGERS; ESSENTIAL COMPONENT; CALCIUM; PINK1; NEURONS; BRAIN;
D O I
10.1007/978-1-4614-4756-6_20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mitochondrial Na+/Ca2+ exchange (NCXmito) is critical for neuronal Ca2+ homeostasis and prevention of cell death from excessive mitochondrial Ca2+ (m[Ca2+]) accumulation. The mitochondrial kinase PINK1 appears to regulate the mCa(2+) efflux from dopaminergic (DAergic) neurons, possibly by directly regulating NCXmito. However, the precise molecular identity of NCXmito is unknown and has been the subject of great controversy. Here we propose that the previously characterised plasmalemmal NCX isoforms (NCX2, NCX3) contribute to mitochondrial Na+/Ca2+ exchange in human DAergic neurons and may act downstream of PINK1 in the prevention of neurodegeneration by m[Ca2+] accumulation. Firstly, we definitively show the existence of a mitochondrial pool of endogenous plasmalemmal NCX isoforms in human DAergic neurons and cell lines using immunolocalisation and fluorescence-assisted organelle sorting (FAOS). Secondly, we demonstrate reduced mitochondrial Ca2+ efflux occurs following inhibition of NCX2 or NCX3 (but not NCX1) using siRNA or antibody blocking. This study has potentially revealed a new molecular target in Parkinson's disease pathology which ultimately may open up new avenues for future therapeutic intervention.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 50 条
  • [41] Etiology and pathogenesis of Parkinson's disease: role of mitochondrial pathology
    Ottolini, Denis
    Cali, Tito
    Brini, Marisa
    RESEARCH AND REPORTS IN BIOCHEMISTRY, 2013, 3 : 55 - 70
  • [42] The Role of Exercise in Maintaining Mitochondrial Proteostasis in Parkinson's Disease
    Li, Jingwen
    Xu, Yanli
    Liu, Tingting
    Xu, Yuxiang
    Zhao, Xiantao
    Wei, Jianshe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [43] The Role of Mitochondrial DNA Individuality in the Pathogenesis of Parkinson’s Disease
    V. S. Sukhorukov
    A. S. Voronkova
    N. A. Litvinova
    T. I. Baranich
    S. N. Illarioshkin
    Russian Journal of Genetics, 2020, 56 : 402 - 409
  • [44] The Role of Mitochondrial DNA Individuality in the Pathogenesis of Parkinson's Disease
    Sukhorukov, V. S.
    Voronkova, A. S.
    Litvinova, N. A.
    Baranich, T. I.
    Illarioshkin, S. N.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (04) : 402 - 409
  • [45] Role of mitochondrial dysfunction in Parkinson's disease - Implications for treatment
    Ramsey, Chenere P.
    Giasson, Benoit I.
    DRUGS & AGING, 2007, 24 (02) : 95 - 105
  • [46] Mechanisms of neurodegeneration in idiopathic Parkinson's disease
    Schulz, Joerg B.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S306 - S308
  • [47] Dysphagia and dopaminergic neurodegeneration in Parkinson's Disease
    Polychronis, S.
    Ribba, B.
    Nasios, G.
    Dardiotis, E.
    Pagano, G.
    MOVEMENT DISORDERS, 2023, 38 : S566 - S566
  • [48] Molecular pathways of neurodegeneration in Parkinson's disease
    Dawson, TM
    Dawson, VL
    SCIENCE, 2003, 302 (5646) : 819 - 822
  • [49] Significance of neuromelanin for neurodegeneration in Parkinson's disease
    Double, KL
    Riederer, P
    Gerlach, M
    DRUG NEWS & PERSPECTIVES, 1999, 12 (06) : 333 - 340
  • [50] The Paths to Neurodegeneration in Genetic Parkinson's Disease
    Abdel-Salam, Omar M. E.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (09) : 1485 - 1512